Article
Use of biomarkers to identify phenotypes and endotypes of severeasthma.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology - 1 Oct 2018
Carr Tara F, Kraft Monica
Abstract excerpt
OBJECTIVE: Severe asthma can be classified into phenotypes and endotypes, which may inform clinicians about inflammatory pathways leading to disease and ultimately guide optimal therapeutic strategy. Biomarkers, objectively measurable characteristics of the disease, are of increasing interest to clinicians and researchers as powerful tools to distinguish among the severe asthma phenotypes and endotypes. The...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
